TLR4 and liver dysplastic nodule: In addition, RAS blockade by using ACE inhibitors or Ang II receptor blockers can downregulate TLR4 expression, resulting in decreasing the expression of proinflammatory cytokines and inhibiting the NF-κB activation as well as slowing the development of DN.